Gregg Polansky

Array ( [id] => 12150017 [patent_doc_number] => 20180021281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'LIPID FORMULATIONS CONTAINING BIOACTIVE FATTY ACIDS AND OTHER BIOACTIVE AGENTS' [patent_app_type] => utility [patent_app_number] => 15/654040 [patent_app_country] => US [patent_app_date] => 2017-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9925 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15654040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12150004 [patent_doc_number] => 20180021268 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'WEIGHT LOSS/REDUCTION OF VISCERAL FAT COMPOUND AND METHOD OF EXTRACTION AND PREPARATION' [patent_app_type] => utility [patent_app_number] => 15/650820 [patent_app_country] => US [patent_app_date] => 2017-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 13456 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15650820 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14326423 [patent_doc_number] => 10294215 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-05-21 [patent_title] => Therapeutically active compounds and their methods of use [patent_app_type] => utility [patent_app_number] => 15/638279 [patent_app_country] => US [patent_app_date] => 2017-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37127 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 668 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15638279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15359427 [patent_doc_number] => 20200015478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => ANTIBACTERIAL COMPOSITION CONTAINING CARYOLAN-1-OL [patent_app_type] => utility [patent_app_number] => 16/335436 [patent_app_country] => US [patent_app_date] => 2017-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3530 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16335436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12138166 [patent_doc_number] => 20180016249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'Methods of Treating an Overweight or Obese Subject' [patent_app_type] => utility [patent_app_number] => 15/617595 [patent_app_country] => US [patent_app_date] => 2017-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14731 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15617595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11954772 [patent_doc_number] => 20170258923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-14 [patent_title] => 'PSMA BINDING LIGAND-LINKER CONJUGATES AND METHODS FOR USING' [patent_app_type] => utility [patent_app_number] => 15/606913 [patent_app_country] => US [patent_app_date] => 2017-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 25015 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15606913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15895075 [patent_doc_number] => 20200147056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => USE OF SIROLIMUS TO TREAT EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PERSISTENT EDEMA [patent_app_type] => utility [patent_app_number] => 16/303932 [patent_app_country] => US [patent_app_date] => 2017-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5937 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16303932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14578437 [patent_doc_number] => 20190216827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => Composite Formulation of Dutasteride and Tadalafil Comprising Glycerol Fatty Acid Ester Derivative or Propylene Glycol Fatty Acid Ester Derivative and Oral Capsule Formulation Comprising the Same [patent_app_type] => utility [patent_app_number] => 16/099482 [patent_app_country] => US [patent_app_date] => 2017-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099482 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16009079 [patent_doc_number] => 20200179382 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => METHODS OF TREATING CIRCADIAN RHYTHM SLEEP DISORDERS [patent_app_type] => utility [patent_app_number] => 16/300335 [patent_app_country] => US [patent_app_date] => 2017-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16300335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13035243 [patent_doc_number] => 10039734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-07 [patent_title] => Eicosapentaenoic acid (EPA) formulations [patent_app_type] => utility [patent_app_number] => 15/493148 [patent_app_country] => US [patent_app_date] => 2017-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 32588 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15493148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12022157 [patent_doc_number] => 20170312256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-02 [patent_title] => 'TRANSDERMAL PARASITICIDAL FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 15/486233 [patent_app_country] => US [patent_app_date] => 2017-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6212 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15486233 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11992401 [patent_doc_number] => 20170296556 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'METHODS OF TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 15/484379 [patent_app_country] => US [patent_app_date] => 2017-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 8460 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15484379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12137021 [patent_doc_number] => 20180015104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 15/483863 [patent_app_country] => US [patent_app_date] => 2017-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18174 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15483863 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15010959 [patent_doc_number] => 10451609 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2019-10-22 [patent_title] => Omega-3 fatty acid nutriceutical composition and optimization method [patent_app_type] => utility [patent_app_number] => 15/477433 [patent_app_country] => US [patent_app_date] => 2017-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6630 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15477433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15571453 [patent_doc_number] => 10576085 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Substituted aminopurine compounds, compositions thereof, and methods of treatment therewith [patent_app_type] => utility [patent_app_number] => 15/475899 [patent_app_country] => US [patent_app_date] => 2017-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 59 [patent_no_of_words] => 42190 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 261 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15475899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13457885 [patent_doc_number] => 20180280485 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-04 [patent_title] => THIORETINAMIDE COMPOSITIONS FOR THE APOPTOSIS OF MALIGNANT CELLS WHILE PREVENTING THE APOPTOSIS OF NORMAL CELLS AND RELATED METHODS [patent_app_type] => utility [patent_app_number] => 15/475103 [patent_app_country] => US [patent_app_date] => 2017-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15475103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11713483 [patent_doc_number] => 20170181983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-29 [patent_title] => 'EXO-S-MECAMYLAMINE FORMULATION AND USE IN TREATMENT' [patent_app_type] => utility [patent_app_number] => 15/456934 [patent_app_country] => US [patent_app_date] => 2017-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12964 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15456934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13368847 [patent_doc_number] => 20180235964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => CXCR-2 INHIBITORS FOR TREATING CRYSTAL ARTHROPATHY DISORDERS [patent_app_type] => utility [patent_app_number] => 15/516465 [patent_app_country] => US [patent_app_date] => 2017-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12768 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15516465 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12562485 [patent_doc_number] => 10016396 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-10 [patent_title] => Dexmedetomidine premix formulation [patent_app_type] => utility [patent_app_number] => 15/444932 [patent_app_country] => US [patent_app_date] => 2017-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11928 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15444932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14452377 [patent_doc_number] => 10322135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-06-18 [patent_title] => Pharmaceutical composition comprising indole compound [patent_app_type] => utility [patent_app_number] => 15/441998 [patent_app_country] => US [patent_app_date] => 2017-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 19 [patent_no_of_words] => 10664 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15441998 [rel_patent_id] =>[rel_patent_doc_number] =>)